The novel porcine Lactobacillus sobrius strain protects intestinal cells from enterotoxigenic Escherichia coli K88 infection and prevents membrane barrier damage

Journal of Nutrition

Volumn 137, Issue 12, 2007, Pages 2709-2716

  Roselli, Marianna ^a   Finamore, Alberto ^a   Britti, Maria Serena ^a   Konstantinov, Sergey R ^b   Smidt, Hauke ^b   De Vos, Willem M ^b   Mengheri, Elena ^a  

^a ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI ENTEROTOXIN; F ACTIN; INTERLEUKIN 10; INTERLEUKIN 8; RIBOSOME RNA;

ARTICLE; BACTERIUM ADHERENCE; CONTROLLED STUDY; ENTEROBACTER INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; LACTOBACILLUS; LACTOBACILLUS SOBRIUS; MEMBRANE DAMAGE; NONHUMAN; PHYLOGENY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ESCHERICHIA COLI; LACTOBACILLUS; LACTOBACILLUS AMYLOVORUS; LACTOBACILLUS SOBRIUS; SUS;

EID: 37149036876     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/137.12.2709     Document Type: Article

References (54)

1. Nusrat A, Turner JR, Madara JL. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol. 2000;279:G851-7.
2. Furuse M, Itoh M, Hirase T, Nagafuchi A, Yonemura S, Tsukita S. Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J Cell Biol. 1994;127:1617-26.
3. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol. 2001;2:285-93.
4. Berkes J, Viswanathan VK, Savkovic SD, Hecht G. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut. 2003;52:439-51.
5. Fasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol. 2005;2:416-22.
6. Sansonetti PJ, Tran Van Nhieu G, Egile C. Rupture of the intestinal epithelial barrier and mucosal invasion by Shigella flexneri. Clin Infect Dis. 1999;28:466-75.
7. Bengmark S, Gil A. Bioecological and nutritional control of disease: prebiotics, probiotics and synbiotics. Nutr Hosp. 2006;21:72-84.
8. Isolauri E, Kirjavainen PV, Salminen S. Probiotics: a role in the treatment of intestinal infection and inflammation? Gut. 2002;50:54-9.
9. Saarela M, Mogensen G, Fonden R, Matto J, Mattila-Sandholm T. Probiotic bacteria: safety, functional and technological properties. J Biotechnol. 2000;84:197-215.
10. Corthesy B, Gaskins HR, Mercenier A. Cross-talk between probiotic bacteria and the host immune system. J Nutr. 2007; (3, Suppl 2) 137:S781-90.
11. Blum S, Schiffrin EJ. Intestinal microflora and homeostasis of the mucosal immune response: implications for probiotic bacteria? Curr Issues Intest Microbiol. 2003;4:53-60.
12. Sheil B, Shanahan F, O'Mahony L. Probiotic effects on inflammatory bowel disease. J Nutr. 2007; (3, Suppl 2) 137:S819-24.
13. Ouwehand AC. Antiallergic effects of probiotics. J Nutr. 2007; (3, Suppl 2) 137:S794-7.
14. Sartor RB. Probiotic therapy of intestinal inflammation and infections. Curr Opin Gastroenterol. 2005;21:44-50.
15. Vaughan EE, de Vries MC, Zoetendal EG, Ben-Amor K, Akkermans ADL, de Vos WM. The intestinal LABs. Antonie Van Leeuwenhoek. 2002;82:341-52.
16. de Vrese M, Marteau RP. Probiotics and prebiotics: effects on diarrhea. J Nutr. 2007; (3, Suppl 2) 137: S803-11.
17. Lievin-Le MoalV, Amsellem R, Servin AL, Coconnier MH. Lactobacillus acidophilus (strain LB) from the resident adult human gastrointestinal microflora exerts activity against brush border damage promoted by a diarrhoeagenic Escherichia coli in human enterocyte-like cells. Gut. 2002;50:803-11.
18. Parassol N, Freitas M, Thoreux K, Dalmasso G, Bourdet-Sicard R, Rampal P. Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells. Res Microbiol. 2005;156:256-62.
19. Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De Simone C. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology. 2001;121:580-91.
20. Resta-Lenert S, Barrett KE. Enteroinvasive bacteria alter barrier and transport properties of human intestinal epithelium: role of iNOS and COX-2. Gastroenterology. 2002;122:1070-87.
21. Konstantinov SR, Poznanski E, Fuentes S, Akkermans ADL, Smidt H, de Vos WM. Lactobacillus sobrius sp. nov., abundant in the intestine of weaning piglets. Int J Syst Evol Microbiol. 2006;56:29-32.
22. Konstantinov SR, Awati A, Williams BA, Miller BG, Jones P, Stokes CR, Akkermans AD, Smidt H, de Vos WM. Post-natal development of the porcine microbiota composition and activities. Environ Microbiol. 2006;8:1191-9.
23. Konstantinov SR, Smidt H. Commensal microbiota is required for the normal development and function of the porcine host immune system and physiology. In: Mengheri E, editor. Nutrition and immunity. Kerala (India): Research Signpost; 2006. p. 23-38.
24. Gonzalez-Vallina R, Wang H, Zhan R, Berschneider HMR, Lee M, Davidson NO, Black DD. Lipoprotein and apolipoprotein secretion by a newborn piglet intestinal cell line (IPEC-1). Am J Physiol. 1996;2:G249-59.
25. Roselli M, Finamore A, Garaguso I, Britti MS, Mengheri E. Zinc oxide protects cultured enterocytes from the damage induced by Escherichia coli. J Nutr. 2003;133:4077-82.
26. Roselli M, Finamore A, Britti MS, Mengheri E. Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response induced by enterotoxigenic Escherichia coli K88. Br J Nutr. 2006;95:1177-84.
27. Roselli M, Britti MS, Le Huerou-Luron I, Marfaing H, Zhu WY, Mengheri E. Effect of different plant extracts and natural substances (PENS) against membrane damage induced by enterotoxigenic Escherichia coli K88 in pig intestinal cells. Toxicol In Vitro. 2007;21:224-9.
28. Nakamura LK. Lactobacillus amylovorus, a new starch-hydrolyzing species from cattle waste-corn fermentation. Int J Syst Bacteriol. 1981;31:56-63.
29. Konstantinov SR, Awati A, Smidt H, Williams BA, Akkermans ADL, de Vos WM. Specific response of a novel and abundant Lactobacillus amylovorus-like phylotype to dietary prebiotics in the guts of weaning piglets. Appl Environ Microbiol. 2004;70:3821-30.
30. Ferruzza S, Scacchi M, Scarino ML, Sambuy Y. Iron and copper alter tight junction permeability in human intestinal Caco-2 cells by distinct mechanisms. Toxicol In Vitro. 2002;16:399-404.
31. Bellovino D, Lanyau Y, Garaguso I, Amicone L, Cavallari C, Tripodi M, Gaetani S. MMH cells: an in vitro model for the study of retinol-binding protein secretion regulated by retinol. J Cell Physiol. 1999;181:24-32.
32. Dozois CM, Oswald E, Gautier N, Serthelon JP, Fairbrother JM, Oswald IP. A reverse transcription-polymerase chain reaction method to analyze porcine cytokine gene expression. Vet Immunol Immunopathol. 1997;58:287-300.
33. Tsukamoto T, Nigam SK. Role of tyrosine phosphorylation in the reassembly of occludin and other tight junction proteins. Am J Physiol. 1999;276:F737-50.
34. Jin LZ, Marquardt RR, Zhao X. A strain of Enterococcus faecium (18C23) inhibits adhesion of enterotoxigenic Escherichia coli K88 to porcine small intestine mucus. Appl Environ Microbiol. 2000;66: 4200-4.
35. Spencer RJ, Chesson A. The effect of Lactobacillus spp. on the attachment of enterotoxigenic Escherichia coli to isolated porcine enterocytes. J Appl Bacteriol. 1994;77:215-20.
36. Gewirtz AT, Liu Y, Sitaraman SV, Madara JL. Intestinal epithelial pathobiology: past, present and future. Best Pract Res Clin Gastroenterol. 2002;16:851-67.
37. Simonovic I, Rosenberg J, Koutsouris A, Hecht G. Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions. Cell Microbiol. 2000;2:305-15.
38. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol. 1999;163:1-5.
39. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology. 2004;127:224-38.
40. Baggiolini M, Loetscher P, Moser B. Interleukin-8 and the chemokine family. Int J Immunopharmacol. 1995;17:103-8.
41. Otte JM, Cario E, Podolsky DK. Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol. 2004;286:G613-26.
42. Brun P, Castagliuolo I, Leo VD, Buda A, Pinzani M, Palu G, Martines D. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2007;292:G518-25.
43. Bolton SJ, Anthony DC, Perry VH. Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience. 1998;86:1245-57.
44. Coyne CB, Vanhook MK, Gambling TM, Carson JL, Boucher RC, Johnson LG. Regulation of airway tight junctions by proinflammatory cytokines. Mol Biol Cell. 2002;13:3218-34.
45. Yamamoto T, Kojim T, Murata M, Takano K, Go MChiba, H, Sawada N. IL-1beta regulates expression of Cx32, occludin, and claudin-2 of rat hepatocytes via distinct signal transduction pathways. Exp Cell Res. 2004;299:427-41.
46. Dieleman LA, Goerres MS, Arends A, Sprengers D, Torrice C, Hoentjen F, Grenther WB, Sartor RB. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut. 2003;52:370-6.
47. Ulisse S, Giochetti P, D'Alo S, Russo FP, Pesce I, Ricci G, Rizzello F, Helwig U, Cifone MG, et al. Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. Am J Gastroenterol. 2001;96:2691-9.
48. Madsen KL, Malfair D, Gray D, Doyle JS, Jewell LD, Fedorak RN. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis. 1999;5:262-70.
49. Suzuki Y, Sher A, Yap G, Park D, Neyer LE, Liesenfeld O, Fort M, Kang H, Gufwoli E. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J Immunol. 2000;164:5375-82.
50. Balkovetz DF, Katz J. Bacterial invasion by a paracellular route: divide and conquer. Microbes Infect. 2003;5:613-9.
51. Boudeau J, Glasser AL, Masseret E, Joly B, Darfeuille-Michaud A. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun. 1999;67:4499-509.
52. Elsinghorst EA, Kopecko DJ. Molecular cloning of epithelial cell invasion determinants from enterotoxigenic Escherichia coli. Infect Immun. 1992;60:2409-17.
53. Francis CL, Jerse AE, Kaper JB, Falkow S. Characterization of interactions of enteropathogenic Escherichia coli O127:H6 with mammalian cells in vitro. J Infect Dis. 1991;164:693-703.
54. Moxley RA, Berberov E, Francis MDH, Xing J, Moayeri M, Welch RA, Baker DR, Barletta RG. Pathogenicity of an enterotoxigenic Escherichia coli hemolysin (hlyA) mutant in gnotobiotic piglets. Infect Immun. 1998;66:5031-5.